AVROBIO Inc. announced the appointment of Ian Clark to its Board of Directors. Ian Clark, former CEO of Genentech, will join as an independent director effective from November 09, 2017. Mr. Clark is currently serving as an Operating Partner within Clarus Ventures. Currently, Mr. Clark serves on the boards of Agios Pharmaceuticals Inc., Corvus Pharmaceuticals Inc. and Shire plc. Mr. Clark recently was a member of the Kite Pharma board until its acquisition by Gilead Inc. Since 2009, he has served on the boards of directors of the Biotechnology Industry Organization, the Gladstone Foundation and the Federal Reserve Bank of San Francisco's Economic Advisory Council.